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Abstract Dynein is a minus end-directed microtubule motor
that serves multiple cellular functions. We have performed a fine
mapping of the 8 kDa dynein light chain (LC8) binding sites
throughout the development of a library of consecutive synthetic
dodecapeptides covering the amino acid sequences of the various
proteins known to interact with this dynein member according to
the yeast two hybrid system. Two different consensus sequences
were identified: GIQVD present in nNOS, in DNA cytosine
methyl transferase and also in GKAP, where it is present twice in
the protein sequence. The other LC8 binding motif is KSTQT,
present in Bim, dynein heavy chain, Kid-1, protein 4 and also in
swallow. Interestingly, this KSTQT motif is also present in
several viruses known to associate with microtubules during
retrograde transport from the plasma membrane to the nucleus
during viral infection. ß 2001 Published by Elsevier Science
B.V. on behalf of the Federation of European Biochemical So-
cieties.
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1. Introduction
Dyneins are large multi-component, microtubule-based mo-
lecular motors that generate force towards the minus end of
microtubules and are involved in several cellular processes
including retrograde transport in axons, ciliary/£agellar beat-
ing, vesicular transport, movement of endosomes and lyso-
somes and positioning of the mitotic spindle [1^3]. From a
structural and functional point of view, the two major classes
of dyneins are the axonemal dyneins involved in £agellar and
ciliary movement, and the cytoplasmic dyneins. In generic
terms, cytoplasmic dyneins are constructed around one or
more heavy chains (HCs), each of which forms a multilobed
globular head structure where the ATP hydrolysis responsible
for the microtubule motor activity takes place. These HCs are
associated to several (probably two) copies of a 74 kDa inter-
mediate chain (IC), four light intermediate chains (LICs) of
50^60 kDa, and several light chains (LCs) with molecular
masses lower than 22 kDa. In the case of cytoplasmic dynein,
this global association of several polypeptide chains results in
a total molecular mass of V1.25 MDa [1^3].
Recently, King and coworkers have identi¢ed and charac-
terised in detail the three LC components of 8 kDa, 14 kDa
and 22 kDa within cytoplasmic dynein [4^7]. The 8 kDa dy-
nein LC (LC8, actual mass 10 kDa) was ¢rst identi¢ed as an
integral component of the Chlamydomonas reinhardtii outer
dynein arm, in association with the ICs at the base of the
soluble particle [8]. To date, at least 10 di¡erent proteins
under study in independent laboratories were used as bait in
a yeast two hybrid experiment and retrieved LC8 as a high
a⁄nity interacting protein. The cellular LC8-associated pro-
teins include the N-terminus region of neuronal nitric oxide
synthase (nNOS) [9], IUBK [10], the renal transcription factor
Kid-1 (Dr Ralph Witzgall, University of Heidelberg, personal
communication), the proapoptotic member of the Bcl-2 family
Bim [11], the product of the Drosophila swallow gene [12],
myosin V [13] and a guanylate kinase domain-associated pro-
tein (GKAP) [13].
We describe herein a new approach that allows a fast anal-
ysis of the LC8 binding sites to be performed within sequences
of proteins that associate with microtubules and become
transported in a retrograde manner. Likewise, we have also
screened other protein sequences suggested to be interacting
with LC8 according to biochemical and structural data.
2. Materials and methods
2.1. Materials
Escherichia coli BL21 DE3 competent cells were from Novagen.
Antibodies against the hexahistidine tag were purchased from Sigma.
The Ni^nitrilotriacetic acid resin was from Qiagen. ECL reagents were
obtained from Amersham-Pharmacia Biotech. Photography ¢lm was
purchased from Kodak. All the other reagents were from Sigma.
2.2. Peptide synthesis
Overlapping dodecapeptides for mapping studies were prepared by
automated spot synthesis (Abimed, Langenfeld, Germany) onto an
amino-derivatised cellulose membrane, immobilised by their C-termini
via a polyethylene glycol spacer, and N-terminal acetylated. We used
a sequential displacement of two amino acids during the synthesis,
which leads to an overlap of 10 residues between each two consecutive
dodecapeptides, an 8 residue overlap among three consecutive do-
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Fig. 1. Binding of LC8 to nNOS. Recombinant LC8 was incubated with a cellulose membrane bearing 144 spots with synthetic dodecapeptides
that cover the ¢rst 300 amino acids of the protein (A). 25 dodecapeptides were synthesised on each line (except line 6 with 19 peptides). The
membrane was developed by ECL after incubation with a peroxidase-labelled anti-hexahistidine tag antibody (B). The underlined sequence
(KDTGIQVD) on line 5 indicates the overlap among peptides 112, 113 and 114.
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decapeptides, a 6 residue overlap among four consecutive dodecapep-
tides, and so on.
2.3. Expression and puri¢cation of the recombinant LC8 proteins
The pET-LC8 plasmid was used to routinely transform BL21 DE3
cells, and LC8 was expressed and puri¢ed as previously reported [14].
In summary, a fresh colony was picked and used to inoculate 2 ml of
LB medium that was grown overnight at 37‡C. This culture was used
to initiate a larger culture of 1 l of 2UYT medium that was grown in
2 l £asks at 230 rpm at 25‡C. Puri¢ed protein eluted from the Ni^
nitrilotriacetic acid column was dialysed against 100 mM (NH4)
HCO3 and frozen in liquid nitrogen. Protein storage was performed
at 320‡C in small aliquots in order to avoid repetitive freeze^thawing.
2.4. Recombinant LC8 binding assays on cellulose-bound peptides
The cellulose membranes were coated with 1% non-fat dried milk in
Fig. 2. Binding of LC8 to various cellular targets. Recombinant LC8 was incubated with cellulose membranes bearing spots with synthetic do-
decapeptides that cover the indicated sequences. Each spot covers a sequence with two amino acids displaced compared to the previous se-
quence. Selected positive spots are boxed and correlated with their corresponding sequence. The membrane was developed by ECL after incu-
bation with a peroxidase-labelled anti-hexahistidine tag antibody.
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TBS (50 mM Tris, pH 7.0, 137 mM NaCl, 2.7 mM KCl) for 4 h at
room temperature. Incubation with the recombinant LC8 (0.13 WM)
was done overnight at room temperature. Three washes (25 ml each)
were performed with TBS^Tween 20 (0.05%). Subsequently, the mem-
brane was incubated for 2 h at room temperature with a commercial
antibody against the hexahistidine tag present in the recombinant
protein (1:100 000 dilution in TBS). Three additional 10 min washes
were performed with TBS^Tween 20 (0.05%), followed by three more
10 min washes with TBS alone. Development of the membrane was
performed by ECL following the manufacturer’s instructions. The
quanti¢cation of the intensity of each spot was performed utilising
a UVI-tec digital image analyser (UVItec, Cambridge, UK) and the
software UVIband V97. In every case, spots corresponding to the
dodecapeptides of the various proteins synthesised onto the same
membrane were compared with each other. Controls performed with
the antibody in the absence of recombinant LC8 were performed in
every case, in order to subtract the non-speci¢c binding due to the
reactivity of the antibody against certain synthetic dodecapeptides.
3. Results
3.1. Binding of LC8 to nNOS
Since a crystallographic, three-dimensional structure of a
peptide of nNOS bound to LC8 is available [15], we decided
to validate our methodology covering a large portion of
nNOS in the form of overlapping synthetic dodecapeptides
and performing a binding assay to recombinant LC8 (Fig.
1). Development was performed using a peroxidase-labelled
antibody that recognises the hexahistidine tag present in the
recombinant LC8. Binding of LC8 to peptides 112, 113 and
114 reveals that the common amino acid sequence to these
three peptides is the KDTGIQVD motif, in accordance with
the yeast two hybrid and crystallographic data [9,15]. The
recognition of LC8 toward peptides that possess this binding
motif is exquisite, since no other dodecapeptide present in the
membrane displays any comparable reactivity. Accordingly,
we undertook the analysis of protein sequences known to
interact to LC8 according to previous yeast two hybrid infor-
mation, as well as several proteins known to be associated to
microtubules.
3.2. Binding of LC8 to cellular targets
In order to perform a ¢ne mapping of the recognition prop-
erties of LC8 towards other cellular proteins, we screened
fragments of 13 di¡erent polypeptides ranging in size from
58 residues (in most of the cases, 24 spots) to 184 residues
(myosin V). Seven of them (Kid-1, Bim, DNA cytosine methyl
transferase, protein 4, dynein HC, swallow and GKAP) re-
turned a positive interaction which converge at two to four
consecutive spots (Fig. 2). In every case, a clear, distinct pat-
tern of interaction was observed. Since two consecutive over-
lapping peptides possess 10 residues in common, and three
consecutive overlapping peptides possess eight residues in
common, we were able to map down the binding motifs to
the minimal recognition sequence. This recognition motifs fall
into two distinct categories, a GIQVD motif and a KSTQT
motif (Table 1), with all the positive sequences falling into one
of the two groups.
The GIQVD motif accepts another hydrophobic L-
branched residue in place of the Ile residue at position two.
In a similar fashion, a Glu residue can substitute for an Asp
residue of position ¢ve. However, the Gly, Gln and Val res-
idues are invariably present in all cases at positions one, three
and four. The KSTQT motif also accept some conservative
substitutions on its sequence, although the Lys, Gln and Thr
residues remain mostly invariant. Position two can tolerate
residues such as Ser, Ala, Leu and Gln, whereas at position
three only residues such as Thr, Ser and Val are observed.
Large regions of six additional proteins failed to show any
positive interaction according to the pepscan technique. These
included IUBK and the actin-based molecular motor myosin
V, in spite of the fact that both of them reportedly do so in
the yeast two hybrid system [10,13]. Thus, the pepscan tech-
nique does not account for the interaction between these pro-
teins and LC8. The other four proteins that failed to give a
positive interaction were known to associate with microtu-
bules (although their interaction with LC8 has not been re-
ported) in addition to having polypeptide sequences that were
somehow similar to the KSTQT or KDTGIQVD motifs.
These were dynamin (with a DSWLQVQ stretch), myosin
HC (KDTQLQLDD), AMP kinase (KDTGISCDPA) and
L-tubulin (GDSDLQLDR).
3.3. Binding of LC8 to viral targets
Recently, it has been shown that rabies virus and its homo-
logue, Mokola virus, bind to LC8 through their P protein,
and both proteins can be co-immunoprecipitated in infected
cells [16,17]. On the other hand, African Swine Fever virus
uses a protein called p54, essential during the ¢rst infective
steps to bind to LC8, and both proteins co-localise at the
microtubular organisation centre during viral infection [18].
This discovery that several viruses are transported in a retro-
grade manner toward the nucleus bound to the dynein multi-
protein complex led us to consider the analysis of sequences
corresponding to these three viral proteins (Fig. 3). By means
of the pepscan technique, we could conclude that the three
viral proteins resulted in positive binding to LC8, and exhibit
binding sequences that fall into the KSTQT motif (Table 1,
Fig. 3).
3.4. Binding of LC8 to the KSTQT motif positioned in di¡erent
sequence environments
A fast inspection of any eukaryotic sequence database re-
veals that there are hundreds of proteins that display either
the KSTQT or the KDGIQVDR motifs, and just a small
Table 1
Summary of the sequences identi¢ed in proteins that interact with
LC8
GIQVD motif
KDT GIQVDR rat nNOS
KDM GIQVDR human nNOSa
RDT GVQVDR rabbit nNOSa
KDL GIQVDR DNA cytosine methyl transferase
LSI GIQVDD GKAP
QSV GVQVEE GKAP
GIQVD general consensus
KSTQT motif
CD KSTQTPS Bim
TT KSTQTQD Kid-1
SA KATQTDF swallow
GS KSTQTVA microtubule-associated protein
QD KLVQTPL dynein HC
ED KSTQTPE Mokola virus
ED KSTQTTS Rabies virus
QN TASQTMS African swine virus
KSTQT general consensus
aThe human and rabbit sequences of nNOS are depicted here in or-
der to show the non-identical residues that can be accommodated
£anking the GIQVD motif.
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subset of them become associated with the dynein multipro-
tein motor. On the other hand, both the NMR and crystal
structures of LC8 bound to target peptides reveal that the
£anking residues also establish binding interactions that sta-
bilise the structure of the complex. Accordingly, we decided to
inspect if the residues that appear just before and after this
minimal binding sequence might somehow modulate the bind-
ing to LC8 and synthesised the KSTQT pentapeptide in di¡er-
ent sequence environments, starting with the twenty natural
amino acids (Fig. 4, left column). Although the LC8 recogni-
tion of the KSTQT motif is favoured by £anking residues
such as Gln, Glu, Thr, Ser, Asp, Gly, His or Lys, it is virtually
abolished by £anking residues such as Trp, Tyr, Ile, Pro, Cys,
Val and Asn. Amino acids in the ¢rst group are either charged
or polar (with the exception of Gly) while the amino acids in
the second group are mostly apolar (with the exception of
Asn). These pieces of data are in agreement with the £anking
residues that appear in the ten proteins characterised previ-
ously that exhibit the KSTQT motif (Table 1). Next, we an-
alysed the e¡ect of the position of the KSTQT motif in the
dodecapeptide by keeping a constant sequence (G, S or GS) at
both ends. Since the dodecapeptides are synthesised starting
from the C-terminus end, the N-terminus is likely to be more
mobile, while the C-terminus end might be, in principle, less
accessible for LC8 to bind. Surprisingly, the general binding
trend seems to favour positions close to the C-terminus end of
the dodecapeptide, with the last three positions being clearly
preferred in any of the three groups of £anking residues (Fig.
4, right column). Strangely enough, when the KSTQT motif is
positioned between residues 5 and 9, it displays a lower inter-
action with LC8 than at positions 4^8 or 6^11, probably due
to unpredictable conformational e¡ects of the synthetic pep-
tides.
4. Discussion
Dyneins are highly complex, microtubule-based molecular
motors that are involved in multiple motile events in the cy-
Fig. 3. Binding of LC8 to viral targets. Recombinant LC8 was incubated with a cellulose membrane bearing 75 spots with synthetic dodecapep-
tides that cover sequences corresponding to three di¡erent viral proteins (A). 25 dodecapeptides were synthesised on each line. The membrane
was developed by ECL after incubation with a peroxidase-labelled anti-hexahistidine tag antibody (B). The underlined sequences represent the
overlap region among consecutive positive spots.
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toplasm (e.g. maintenance of the Golgi apparatus, vesicular
transport, spindle formation, etc.) and also function to pro-
vide the motive force for ciliary and £agellar beating [1^3].
The molecular mass of the dynein motor is estimated to be
approximately 1^2 MDa, due to the numerous polypeptides
that form the dynein molecular complex, including HCs, ICs,
LICs and LCs. Two of the LCs located within the basal do-
main of the dynein particle, LC8 and Tctex1, shared by both
£agellar and cytoplasmic dyneins, have also been recently re-
garded as tight binders of cargo.
The LC8 polypeptide was ¢rst identi¢ed as an integral com-
ponent of the Chlamydomonas outer dynein arm where it is
associated with the ICs at the base of the soluble particle [8].
Remarkably, subsequent biochemical studies have determined
that the LC8 protein is a stoichiometric component of both
brain cytoplasmic dynein and also the actin-based molecular
motor, myosin V [5,13,19]. The three-dimensional structure of
LC8 has been solved recently by both crystallography [15] and
multi-dimensional NMR [20^22]. Following the isolation of
LC8 as a nNOS interacting protein capable of dissociating the
nNOS dimeric structure [9], two subsequent reports seemed to
challenge this hypothesis suggesting that LC8 might be just
involved in nNOS binding and its transport along microtu-
bules towards the post-synaptic neuronal end [14,23]. Interest-
ingly, in the last few years, at least nine additional proteins,
apparently with no connection among them, have been re-
ported to bind to LC8 using a yeast two hybrid approach
[9^13,16^18].
We report herein a new method to inspect the interaction of
both putative and previously described LC8 binding proteins
with dynein LC by means of the pepscan technique. Synthesis
of peptides composed of 12 consecutive amino acids bound to
a solid support (cellulose membrane) allowed us to perform a
¢ne mapping of the sequence requirements present in LC8
interacting proteins. Optimisation of the assay using nNOS
as a control sequence con¢rmed the validity of our approach,
since the binding was restricted to the sequence stretch present
in the crystal and NMR structures [15,20^22]. Two homolo-
gous sequences to the nNOS motif KDTGIQVD were found
in GKAP (LSIGIQVDD and also QSVGVQVEE) and in cy-
tosine methyl transferase (KDLGIQVDR) (Table 1). Se-
quence comparison among the proteins that possess the
KDTGIQVD motif, including two other nNOS sequences
(human and rabbit), enables us to predict that it is very likely
that human proteins such as centaurin L2 (with a
DKDSGVRYDRV sequence), as well as KIAA0041 protein
(with a MKDLGAQLDRD), will also be associated with LC8
in vivo.
Using the same methodology, we have been able to identify
several novel proteins that also bind to LC8 through sequen-
ces that are identical or homologous to the KSTQT motif
(Fig. 2). Kid-1 renal transcription factor is known to associate
to LC8 in a yeast two hybrid experiment (Dr Ralph Wirzgall,
personal communication). Our data indicate that this interac-
tion is mediated by a TKSTQTQD motif (Fig. 2) present in its
sequence downstream the Kru«ppel-associated box (KRAB) B
[24]. In a similar manner, microtubule-associated protein 4
binds to LC8 through a SKSTQTVA polypeptide stretch
and dynein HC through a VQDKLVQTPL motif. Finally,
both Bim and the Drosophila swallow protein, two other pro-
teins known to bind to LC8 in a yeast two hybrid method-
ology display the KSTQT and KATQT motifs respectively,
and also interact strongly with LC8 according to our results.
When all the polypeptide sequences that successfully inter-
act with LC8 were compared to each other, we could infer
that although the KSTQT motif is highly conserved among
LC8 interacting proteins, the Ser residue at the second posi-
tion can be substituted by Ala, Leu or even Gln (Table 1).
Support for this is provided by random mutagenesis studies of
the LC8 binding sites of Bim [16] and glutathione S-transfer-
ase constructs [25], that also constrict the binding site to this
pentapeptide.
Both NMR [20,21] and site-directed mutagenesis data [25]
indicate that LC8 needs additional contacts with the side
chain of residues £anking the KSTQT motif when interacting
with a target protein. Positioning the KSTQT motif between
the 20 possible natural amino acids enabled us to investigate
the various side chains of amino acids that are capable of
providing constructive interactions inside the LC8 binding
groove (Fig. 4). Interestingly, the presence of the KSTQT
stretch within a synthetic dodecapeptide is not su⁄cient to
provide a positive interaction with LC8. However, polar res-
idues such as Asp, Ser, Thr or Asn preceding the KSTQT
motif convey on LC8 the ability to recognise the amino acid
Fig. 4. Binding of LC8 to the KSTQT motif positioned in di¡erent
sequence environments. Recombinant LC8 was incubated with a cel-
lulose membrane bearing 44 spots with synthetic dodecapeptides
where the KSTQT is introduced within di¡erent sequence environ-
ments. The membrane was developed by ECL after incubation with
a peroxidase-labelled anti-hexahistidine tag antibody.
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pattern (Table 1, Fig. 4), unlike hydrophobic residues such as
Tyr, Ile, Pro, Cys or Val, that abrogate this interaction (Fig.
4).
It is tempting to speculate that due to the dimeric structure
of LC8 [14,15,26], one of the binding sites might be occupied
by members of the dynein protein complex, with the other one
being used for cargo transport. This inference is strengthened
by the observed binding of LC8 to the dynein HC through the
VQDKLVQTPL motif (Fig. 2) and by sequence alignment
programs that revealed that dynein IC, known to be present
with LC8 in a 1:1 stoichiometric ratio in cytoplasmic dynein
[5], displays a YSKETQTPL motif in its sequence. In addi-
tion, an elegant report from Zhang and coworkers has re-
cently demonstrated that dynein IC is also able to interact
with LC8 [25].
It is also noteworthy, in this context, that two viruses from
distant families share a common way of interaction with LC8
that most likely has an immediate importance in the viral life
cycle. In both cases, this interaction results in the direct tar-
geting towards the nuclear membrane, suggesting that viral
proteins are able to hijack the cellular machinery in order to
gain access to the nuclear membrane.
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